drugset / Trial / NCT05848440
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants
RandomizedSequentialDouble-blindTreatment
Summary
This is a Phase I Randomised Single-blind Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants.
Timeline
- Start
- 2023-05-02
- Primary completion
- 2023-11-13
- Completion
- 2023-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD9550 | Other / unclassified | — | Subcutaneous |